Nuclear DVL has been shown to bind to Wnt target genes24,26, promoters that drive aromatase overexpression in cancer, and play a cell-type and paralog-dependent role in activating or repressing CYP19A1 tissue-specific promoters for transcription27. This evidence concerns the gene CYP19A1 and cancer.